Lopez-Granados E, Stacey M, Kienzler A-K, Sierro S, Willberg C B, Fox C P, Rigaud S, Long H M, Hislop A D, Rickinson A B, Patel S, Latour S, Klenerman P, Chapel H
Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK; Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Clin Exp Immunol. 2014 Dec;178(3):470-82. doi: 10.1111/cei.12427.
Mutations in the X-linked inhibitor of apoptosis (XIAP) gene have been associated with XLP-like disease, including recurrent Epstein-Barr virus (EBV)-related haemophagocytic lymphohystiocytosis (HLH), but the immunopathogenic bases of EBV-related disease in XIAP deficiency is unknown. We present the first analysis of EBV-specific T cell responses in functional XIAP deficiency. In a family of patients with a novel mutation in XIAP (G466X) leading to a late-truncated protein and varying clinical features, we identified gradual hypogammaglobulinaemia and large expansions of T cell subsets, including a prominent CD4(+) CD8(+) population. Extensive ex-vivo analyses showed that the expanded T cell subsets were dominated by EBV-specific cells with conserved cytotoxic, proliferative and interferon (IFN)-γ secretion capacity. The EBV load in blood fluctuated and was occasionally very high, indicating that the XIAP(G466X) mutation could impact upon EBV latency. XIAP deficiency may unravel a new immunopathogenic mechanism in EBV-associated disease.
X连锁凋亡抑制蛋白(XIAP)基因的突变与XLP样疾病有关,包括复发性爱泼斯坦-巴尔病毒(EBV)相关的噬血细胞性淋巴组织细胞增生症(HLH),但XIAP缺乏时EBV相关疾病的免疫致病基础尚不清楚。我们首次分析了功能性XIAP缺乏时EBV特异性T细胞反应。在一个XIAP发生新型突变(G466X)导致截短蛋白且临床特征各异的患者家族中,我们发现了逐渐出现的低丙种球蛋白血症以及T细胞亚群的大量扩增,包括一个显著的CD4(+)CD8(+)群体。广泛的体外分析表明,扩增的T细胞亚群以具有保守细胞毒性、增殖能力和干扰素(IFN)-γ分泌能力的EBV特异性细胞为主。血液中的EBV载量波动,偶尔非常高,表明XIAP(G466X)突变可能影响EBV潜伏。XIAP缺乏可能揭示了EBV相关疾病一种新的免疫致病机制。